Source: LeanLife Health Inc.
  • LeanLife Health (LLP) has closed a first tranche of a $1M private placement for proceeds of $365,000
  • The company issued a total of 7,300,000 units at a price of $0.05 per unit 
  • The company intends to use the proceeds for general capital purposes & towards the licensing agreement/product purchase orders with Foodcare
  • LeanLife Health offers high-quality omega3 plant-based oils as well as its line of Iron Energy drinks
  • LeanLife Health (LLP) is unchanged on the day, trading at C$0.04 per share at 1 pm EST

LeanLife Health (LLP) has closed a first tranche of it $1 million private placement for proceeds of $365,000.

The company issued a total of 7,300,000 units at a price of $0.05 per unit. 

Each unit consists of of one common share and one-half a transferrable share purchase warrant. Each whole warrant will entitle the holder to purchase an additional share at a price of $0.075 per for a 2-year period.

All the securities issued are subject to a four month statutory hold period.

The warrants are subject to an acceleration clause.

LeanLife will pay finder’s fees totalling $27,000 in cash, and 540,000 in finders warrants. 

The company intends to use the proceeds for general capital purposes & towards the licensing agreement/product purchase orders with Foodcare.

LeanLife Health offers high-quality omega3 plant-based oils as well as its line of Iron Energy drinks.

LeanLife Health (LLP) is unchanged on the day, trading at C$0.04 per share at 1 pm EST.

More From The Market Online

“Paw Patrol” owners see a 52-week share price high

Spin Master (TSX:TOY) reported 8.9 per cent revenue growth to US$436.4 million and returned to profitability.

EU authorizes new COVID vaccine from Pfizer and BioNTech

The EU grants marketing authorization to Pfizer and BioNTech's COVID-19 vaccine targeting the new XFG variant.

Uber Eats expands grocery delivery network with new U.S. regional retail partners

Uber (NYSE:UBER) Eats added Busch’s Fresh Food Market, Hays, and Lowe’s Market to its grocery delivery marketplace across the U.S.

PharmaTher evaluating 3D printing for personalized peptide medicines

PharmaTher is out to evaluate its GMP-ready 3D printing platform for producing personalized peptide medicines with customized doses.